EpiVacCorona

URI: https://gptkb.org/entity/EpiVacCorona

GPTKB entity

Statements (98)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:administeredBy	gptkb:Algeria gptkb:Angola gptkb:Argentina gptkb:Armenia gptkb:Azerbaijan gptkb:Bahrain gptkb:Bangladesh gptkb:Belarus gptkb:Bolivia gptkb:Botswana gptkb:Burkina_Faso gptkb:Cambodia gptkb:Cameroon gptkb:Chad gptkb:Ecuador gptkb:Egypt gptkb:Ethiopia gptkb:Georgia gptkb:Ghana gptkb:Guatemala gptkb:Hungary gptkb:India gptkb:Indonesia gptkb:Iran gptkb:Iraq gptkb:Ivory_Coast gptkb:Jordan gptkb:Kazakhstan gptkb:Kenya gptkb:Kuwait gptkb:Kyrgyzstan gptkb:Laos gptkb:Lebanon gptkb:Libya gptkb:Madagascar gptkb:Malawi gptkb:Malaysia gptkb:Mali gptkb:Mexico gptkb:Moldova gptkb:Mongolia gptkb:Morocco gptkb:Mozambique gptkb:Myanmar gptkb:Namibia gptkb:Nepal gptkb:Nicaragua gptkb:Niger gptkb:Nigeria gptkb:Oman gptkb:Pakistan gptkb:Palestine gptkb:Paraguay gptkb:Philippines gptkb:Qatar gptkb:Russia gptkb:Saudi_Arabia gptkb:Senegal gptkb:Serbia gptkb:South_Africa gptkb:Sri_Lanka gptkb:Sudan gptkb:Syria gptkb:Tajikistan gptkb:Tanzania gptkb:Thailand gptkb:Tunisia gptkb:Turkey gptkb:Turkmenistan gptkb:Uganda gptkb:Uzbekistan gptkb:Venezuela gptkb:Vietnam gptkb:Yemen gptkb:Zambia gptkb:Zimbabwe UAE
gptkbp:alternativeName	gptkb:ЭпиВакКорона
gptkbp:approvalYear	October 2020
gptkbp:clinicalTrialPhase	Phase III (as of 2021)
gptkbp:contains	synthetic peptide antigens
gptkbp:containsAdjuvant	aluminum hydroxide
gptkbp:countryOfOrigin	gptkb:Russia
gptkbp:developedBy	gptkb:Vector_Institute
https://www.w3.org/2000/01/rdf-schema#label	EpiVacCorona
gptkbp:intervalBetweenDoses	21-28 days
gptkbp:numberOfDoses	2
gptkbp:routeOfAdministration	intramuscular
gptkbp:status	emergency use in Russia
gptkbp:storage	2-8°C
gptkbp:target	gptkb:COVID-19
gptkbp:type	peptide vaccine
gptkbp:WHOStatus	not approved by WHO
gptkbp:bfsParent	gptkb:EpiVacCorona_COVID-19_vaccine gptkb:State_Research_Center_of_Virology_and_Biotechnology_VECTOR gptkb:COVID-19_pandemic_in_Russia
gptkbp:bfsLayer	7